| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0595873B1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/05/2000 | EP0479866B1 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus |
| 04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
| 04/05/2000 | CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | CN1249195A Vector for gene therapy of rh TPO insect bacillar virus and its preparing process and application |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/04/2000 | US6046380 Dna which is modified at cryptic splice sites; for improved yield and gene therapy |
| 04/04/2000 | US6046320 Compound 8 to 30 nucleobases in length which hybridizes a human nucleic acid which encodes an oncogene, mdm2-like p53 binding protein; for therapy or prophylaxis of related diseases |
| 04/04/2000 | US6046319 Antisense oligodeoxynucleotides regulating expression of TNF-α |
| 04/04/2000 | US6046317 For screening for carrier status and diagnosis of predisposition for increased serum cholesterol or low density lipoprotein cholesterol level in humans |
| 04/04/2000 | US6046315 Disease associated calmodulin protein |
| 04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
| 04/04/2000 | US6046173 Polyoma virus pseudocapsids and method to deliver material into cell |
| 04/04/2000 | US6046166 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 04/04/2000 | US6046157 Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides |
| 04/04/2000 | US6046049 Compound 8 to 30 nucleobases in length targeted to 3' untranslated region of nucleic acid which encodes human phosphatidyl inositol 3' kinase p110 delta isoform found in leukocytes; diagnosis, treatment of related diseases |
| 04/04/2000 | US6046047 Genetic construct encoding a chimeric protein with a domain which binds and crosslinks a synthetic, membrane permeable, non-peptide ligand and domain to cause cellular localization of complex; for gene therapy and inducible gene expression |
| 04/04/2000 | US6046044 Cisplatin resistance proteins |
| 04/04/2000 | US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such |
| 04/04/2000 | US6046009 Diagnosis and treatment of glaucoma |
| 04/04/2000 | US6046007 Administering to the subject an effective amount of a polypeptide having crma biological activity and under suitable conditions such that t cells remain viable. |
| 04/04/2000 | US6045999 Transcription factor E2F-4 |
| 04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
| 04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/04/2000 | US6045807 Method for production of neuroblasts |
| 04/04/2000 | US6045802 Antitumor agents treating cancer |
| 04/04/2000 | US6045792 Human proteins kinases |
| 04/04/2000 | US6045789 Bystander effect tumoricidal therapy by expressing an HSV-tk gene |
| 04/02/2000 | CA2246664A1 Vascular specific regulatory elements contained in the desmin 5' flanking region |
| 04/01/2000 | CA2246005A1 Hybrid genes for gene therapy in erythroid cells |
| 03/30/2000 | WO2000017375A2 Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
| 03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 03/30/2000 | WO2000017366A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017353A1 Ucp4 |
| 03/30/2000 | WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 03/30/2000 | WO2000017346A2 Hairpin hybridizer molecules for modulation of gene expression |
| 03/30/2000 | WO2000017345A1 Ly6h gene |
| 03/30/2000 | WO2000017325A1 Trophoblast cell preparations |
| 03/30/2000 | WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 03/30/2000 | WO2000017232A2 Regulatory protein from human keratinocytes |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000016848A1 Systems and methods for treating ischemia |
| 03/30/2000 | WO2000016807A1 Cationic compounds and their use as macro molecular carriers |
| 03/30/2000 | WO2000016800A2 Methods of treating chronic pain |
| 03/30/2000 | WO2000016799A1 Methods of treating chronic pain |
| 03/30/2000 | WO2000016631A1 Murf2 |
| 03/30/2000 | WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 03/30/2000 | WO2000008196A3 Urate oxidase |
| 03/30/2000 | WO1999067393A3 Aav scleroprotein, production and use thereof |
| 03/30/2000 | WO1999067288A9 Tumor antigen peptides originating in cyclophilin b |
| 03/30/2000 | WO1999066959A9 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/30/2000 | WO1999063101A9 Transfected cells and methods for treating diabetes |
| 03/30/2000 | WO1999061066A9 Convection-enhanced delivery of aav vectors |
| 03/30/2000 | WO1999055831A3 Adenoviral vectors for treating disease |
| 03/30/2000 | WO1999042477A3 Transporter protein for saccharide-coupled medicaments |
| 03/30/2000 | CA2345397A1 Trophoblast cell preparations |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2343931A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 03/30/2000 | CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 03/30/2000 | CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | CA2343324A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | CA2343321A1 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 03/30/2000 | CA2343090A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | CA2343067A1 Hairpin hybridizer molecules for modulation of gene expression |
| 03/30/2000 | CA2342957A1 Regulatory protein from human keratinocytes |
| 03/30/2000 | CA2342773A1 Interferon-epsilon |
| 03/29/2000 | EP0989184A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding |
| 03/29/2000 | EP0988862A2 Formulation for use in immunisation |
| 03/29/2000 | EP0988548A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma |
| 03/29/2000 | EP0988391A2 Recombinant adenoviral vectors comprising a splicing sequence |
| 03/29/2000 | EP0988390A1 Alternatively targeted adenovirus |
| 03/29/2000 | EP0988389A1 Method for the production of non-group c adenoviral vectors |
| 03/29/2000 | EP0988388A2 Ghrh expression system and methods of use |
| 03/29/2000 | EP0988379A1 Ldl-receptor |
| 03/29/2000 | EP0988377A1 Zinc finger protein derivatives and methods therefor |
| 03/29/2000 | EP0988376A2 Noey2 gene compositions and methods of use |
| 03/29/2000 | EP0988373A1 Selection marker |
| 03/29/2000 | EP0988370A1 Electrospraying apparatus and method for introducing material into cells |
| 03/29/2000 | EP0988319A1 Human l105 proteins and polynucleotides encoding same |
| 03/29/2000 | EP0988061A1 Methods for delivering bioactive agents |
| 03/29/2000 | EP0988059A2 Human quinone reductase 2 conjugates for adept and gdept |
| 03/29/2000 | EP0988052A2 An influenza enveloped dna vaccine |
| 03/29/2000 | EP0988047A1 Soluble ctla4 mutant molecules and uses thereof |
| 03/28/2000 | US6043390 Useful for the intracellular delivery of polynucleotides; cationic lipids useful in the preparation of liposomes and other lipid vesicles for the delivery of nucleic acids into mammalian cells |
| 03/28/2000 | US6043348 Antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2000 | US6043346 Antibody that binds to a tub polypeptide |
| 03/28/2000 | US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide |
| 03/28/2000 | US6043221 Method for preventing and treating hearing loss using a neuturin protein product |
| 03/28/2000 | US6043212 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 03/28/2000 | US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides |
| 03/28/2000 | US6043083 Inhibitors of the JNK signal transduction pathway and methods of use |
| 03/28/2000 | US6043082 Two genetic constructs encoding chimeric proteins, each with ligand binding domain to complex with the other protein; one protein also with domain which induces biological process, the other having intracelluar targeting domain; gene therapy |
| 03/28/2000 | US6043081 Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions |